Brief: Zymeworks Gets FDA Clearance Of Investigational New Drug Application For ZW191
22/07/2024 12:34
July 22 (Reuters) - Zymeworks Inc ZYME.O :
* ZYMEWORKS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
APPLICATION FOR ZW191, A NOVEL FOLATE RECEPTOR-⍺ TARGETED
TOPOISOMERASE I INHIBITOR ANTIBODY-DRUG CONJUGATE
* ZYMEWORKS INC - FDA CLEARS IND APPLICATION FOR ZW191
Source text for Eikon: ID:nGNX4b0l6S
Further company coverage: ZYME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug